Welcome to our dedicated page for Quantum Computing SEC filings (Ticker: QUBT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Quantum Computing Inc. filings document the company’s Nasdaq-listed common stock, quantum optics and integrated photonics business, governance matters and material corporate events. Current reports cover operating and financial results, material agreements, capital-structure disclosures, acquisitions or dispositions, executive appointments and related exhibits.
Proxy materials address annual meeting procedures, board matters, compensation arrangements and shareholder voting. The filing record also documents the completed acquisition of Luminar Semiconductor, including transaction reporting and supplemental financial statements, alongside disclosures about QCi’s TFLN foundry services, photonic-chip manufacturing, quantum machines and product areas in AI, high-performance computing, cybersecurity and remote sensing.
The filing excerpts list several selling stockholder positions and related figures, including a line showing 2,938,220 shares and other share counts (for example 11,466,879, 10,331,313, 6,405,120). It also discloses specific offering-related expenses: Accounting fees $10,000.00, Legal fees $75,000.00, Transfer agent and registrar fees $1,500.00, and Printing expenses $15,000.00. The excerpt names several individuals and entities tied to the company and selling holders, including Funicular Funds, LP, Cable Car Capital, LP, Regal Funds Management Pty Ltd. and board members such as Dr. Yuping Huang and Christopher Roberts.
Quantum Computing Inc. entered into securities purchase agreements for a private placement of 37,183,937 shares of common stock, generating gross proceeds of approximately $750 million before fees and expenses. The shares were issued in a non-public transaction relying on exemptions under Section 4(a)(2) and/or Regulation D.
The company must file a registration statement to allow resale of these shares by October 23, 2025. Under the purchase and placement agency agreements, the company agreed for 75 days after the October 8, 2025 closing not to issue or register additional equity, subject to customary exceptions. Directors and executive officers separately agreed to 60‑day lock-ups restricting sales or hedging of their holdings.
Titan Partners Group LLC acted as exclusive placement agent and will receive a 4% cash fee on the total placement size plus up to $100,000 for fees and expenses.
Quantum Computing Inc. (QUBT) filed an S-3ASR prospectus containing standard risk disclosures, proposed resale methods for securities, a schedule of offering expenses and a list of recent SEC reports. The filing lists multiple blocks of outstanding shares with associated percentages including 5,803,331 (3.11%), 6,716,819 (3.59%), 5,373,455 (2.88%), 4,030,092 (2.16%), 2,686,727 (1.44%) and 913,488 (*). Permitted sale methods include ordinary brokerage, block trades, principal purchases and privately negotiated transactions. Estimated offering-related expenses shown are Accounting $10,000, Legal $75,000, Transfer agent $1,500, and Printing $15,000. The prospectus references the company’s Annual Report filed March 20, 2025 and Quarterly Reports filed May 15, 2025 and August 14, 2025, plus multiple Current Reports filed on specific 2025 dates. Named individuals include Dr. Yuping Huang, Christopher Roberts, Michael Turmelle, Robert Fagenson, Dr. Carl Weimer, Dr. Javad Shabani and Eric M. Schwartz.
Quantum Computing Inc. entered into securities purchase agreements for a private placement of 26,867,276 shares of common stock, generating gross proceeds of approximately $500 million before placement agent commissions and other expenses. The placement closed on September 24, 2025 and the shares were issued under Securities Act exemptions for non‑public offerings.
The company must file a registration statement to allow resale of the placement shares by October 9, 2025. For 75 days after closing, it agreed not to issue or agree to issue additional common stock or equivalents, or file new registration statements, without placement agent and purchaser consent, subject to customary exceptions. Directors and executive officers also signed 60‑day lock‑up agreements restricting sales and registrations of their holdings. Titan Partners Group LLC acted as exclusive placement agent, earning a 5% cash fee on the placement size plus up to $100,000 for reimbursed expenses.
Yuping Huang, who serves as Director and is identified as a 10% owner and CEO/President of Quantum Computing Inc. (QUBT), reported a transaction dated 09/12/2025. The Form 4 shows a gift (transaction code G(1)) of 400,000 shares of common stock to a charitable trust at a reported price of $0. After the transaction, the reporting person beneficially owned 20,887,718 shares (reported as direct ownership). The form is signed by Yuping Huang on 09/17/2025. No derivative securities are reported and no other transactions are listed.
Robert B. Fagenson, a director of Quantum Computing Inc. (QUBT), reported multiple open-market sales of the company's common stock in a Form 4 filed September 17, 2025. The filings show a sequence of sales on September 9, 10, 11, 12 and 15, 2025 at prices ranging from $15.0199 to $16.882 per share. In total, the reporting person or an entity he manages sold 100,000 shares, and the reported beneficial ownership after the final reported transaction on September 15, 2025 is shown as 0 shares. The Form identifies the seller as Fagenson Fixed Income Partners, LLC, for which Mr. Fagenson is the managing member, and indicates the reporter files as an issuer director.
Quantum Computing Inc. director Javad Shabani exercised and sold company shares through August–September 2025. On 08/18/2025 Mr. Shabani exercised 40,000 non‑qualified stock options granted 05/10/2024 (exercise price $1.00) using a net cashless exercise at a $15.84 per‑share calculation, resulting in issuance of 37,474 shares. He sold 20,000 shares on 09/05/2025 at $15.30 and sold the remaining 17,474 shares on 09/08/2025 at $15.26, leaving 0 shares beneficially owned following the transactions.
Yuping Huang, identified as a Director, 10% owner and CEO, President of Quantum Computing Inc. (QUBT), reported a sale of common stock on 09/04/2025. The filing shows 1,000,000 shares were disposed of at a price of $14.415 per share. After the reported transaction, the filing states 21,287,718 shares remained beneficially owned. The Form 4 is signed by Yuping Huang on 09/05/2025 and contains no derivative transactions or additional explanatory text.
Quantum Computing Inc. (QUBT) reporting person Diane Pouya, Chief Revenue Officer and director, exercised stock options and sold shares in August 2025. On 08/18/2025 Pouya exercised vested non‑qualified options that were granted 10/04/2024 (amended 03/21/2025) to purchase up to 55,000 shares at a $1.00 exercise price, using a cashless "net exercise" at an effective cashless exercise price of $15.841 per share, resulting in issuance of 17,175 shares.
On 08/25/2025 Pouya sold the 17,175 shares at $15.5347 per share. After these transactions the Form 4 reports 36,667 option shares outstanding (derivative securities) and the reported direct beneficial ownership change reflects the exercised and sold shares. The filing is a routine Section 16 disclosure of insider exercise and sale activity.
Quantum Computing Inc. (QUBT) filing of Form 144 notifies the proposed sale of 1,000,000 shares of common stock through J.P. Morgan Securities LLC with an aggregate market value of $14,550,000 and an approximate sale date of 09/04/2025 on NASDAQ. The shares were originally acquired on 07/05/2022 as merger consideration in connection with the combination of Qphoton, Inc. and Quantum Computing Inc., totaling 23,953,706 shares received in that transaction. The filer also reported a sale on 03/26/2025 of 200,000 shares generating $1,696,472.83 in gross proceeds. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.